BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19542492)

  • 1. Temporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity.
    Abboud K; Bassila JC; Ghali-Ghoul R; Sabra R
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H836-45. PubMed ID: 19542492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phosphodiesterase 5 inhibitor on alteration in vascular smooth muscle sensitivity and renal function in rats with liver cirrhosis.
    Tahseldar-Roumieh R; Ghali-Ghoul R; Lugnier C; Sabra R
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H481-8. PubMed ID: 16373593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
    Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms.
    Roghani M; Baluchnejadmojarad T
    Vascul Pharmacol; 2009; 51(2-3):84-9. PubMed ID: 19393342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta.
    Malakul W; Thirawarapan S; Suvitayavat W; Woodman OL
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):192-200. PubMed ID: 17941894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of endothelium-derived hyperpolarizing factor (EDHF) up-regulation in endothelial dysfunction in aorta in diabetic rats.
    Csanyi G; Lepran I; Flesch T; Telegdy G; Szabo G; Mezei Z
    Pharmacol Rep; 2007; 59(4):447-55. PubMed ID: 17901574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species.
    Karasu C
    Eur J Pharmacol; 2000 Mar; 392(3):163-73. PubMed ID: 10762670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
    Ajay M; Achike FI; Mustafa MR
    Pharmacol Res; 2007 May; 55(5):385-91. PubMed ID: 17317209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin-diabetic rats.
    Cinar MG; Ulker S; Alper G; Evinç A
    Pharmacology; 2001 Jan; 62(1):56-64. PubMed ID: 11150923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Balaraman R
    Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilatory activity and antihypertensive profile mediated by inhibition of phosphodiesterase type 1 induced by a novel sulfonamide compound.
    Pontes LB; Antunes F; Sudo RT; Raimundo JM; Lima LM; Barreiro EJ; Zapata-Sudo G
    Fundam Clin Pharmacol; 2012 Dec; 26(6):690-700. PubMed ID: 22066694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
    McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
    Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium.
    Ortíz MC; Fortepiani LA; Martínez C; Atucha NM; García-Estañ J
    Clin Sci (Lond); 1996 Dec; 91(6):733-8. PubMed ID: 8976809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific vascular responses of the rat aorta: effects of moderate term (intermediate stage) streptozotocin-induced diabetes.
    Han X; Shaligram S; Zhang R; Anderson L; Rahimian R
    Can J Physiol Pharmacol; 2016 Apr; 94(4):408-15. PubMed ID: 26845285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic rats.
    Goirand F; Ovide-Bordeaux S; Renaud JF; Grynberg A; Lacour B
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):184-90. PubMed ID: 15743401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase and thromboxane/prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats.
    Graham DA; Rush JW
    J Appl Physiol (1985); 2009 Oct; 107(4):1059-67. PubMed ID: 19696359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.